News

Filter

Current filters:

None

8011 to 8020 of 96292 results

Domain partners with RusNano on drug production in Russia

07-03-2012

Russian state nanotechnology corporation RusNano and Domain Associates, a US venture fund, are to invest…

Domain AssociatesEuropeFinancialPharmaceuticalRusNano

New pharma plant in Tanzania to produce ARVs

07-03-2012

Tanzania will start the first domestic commercial production of antiretroviral (ARV) drugs in the next…

Anti-viralsGenericsMarkets & MarketingRest of the World

Forest Labs and Pierre Fabre's levomilnacipran positive in Ph III

07-03-2012

US drugmaker Forest Laboratories (NYSE: FRX) and France-based Pierre Fabre have announced positive top-line…

Forest LaboratorieslevomilnacipranNeurologicalPharmaceuticalPierre FabreResearch

Merck KGaA 4th-qtr profits triple, but miss expectations

07-03-2012

German drug major Merck KGaA (MRK: DE) posted a massive improvement in fourth-quarter 2011 net profit,…

FinancialMerck KGaAPharmaceutical

FDA nod for Discovery Labs Surfaxin for RDS

07-03-2012

US specialty drugmaker Discovery Laboratories (Nasdaq: DSCO) saw its shares rocker 30% to $4.88 in after-hours…

Discovery LaboratoriesNorth AmericaPharmaceuticalRegulationRespiratory and PulmonarySurfaxin

Roche has options beyond Illumina

07-03-2012

Speaking at the companys annual meeting, Swiss drug maj'or Roche (ROG: SIX) chairman Franz Humer said:…

FinancialIlluminaMergers & AcquisitionsPharmaceuticalRoche

Aegerion files for lomitapide approval in USA and Europe

07-03-2012

Emerging US biotech firm Aegerion Pharmaceuticals (Nasdaq: AEGR) has submitted a New Drug Application…

Aegerion PharmaceuticalsBiotechnologyEuropelomitapideNorth AmericaRare diseasesRegulation

German biotech sector starts 2012 less optimistic

06-03-2012

Despite a more positive assessment of their current situation, German biotechnology companies are starting…

BiotechnologyEuropeFinancialResearch

8011 to 8020 of 96292 results

Back to top